scholarly journals THE RELATIONSHIP BETWEEN.THE CHEST RADIOGRAPH, REGION AL LUNG FUNCTION USING N2, EXERCISE TOLERANCE AND CLINICAL CONDITION IN CHILDREN WITH CYSTIC FIBROSIS

1977 ◽  
Vol 11 (4) ◽  
pp. 568-568
Author(s):  
A L Coates ◽  
P Boyce ◽  
D G Shore ◽  
M Mearns ◽  
S Godfrey ◽  
...  
2002 ◽  
Vol 165 (6) ◽  
pp. 762-765 ◽  
Author(s):  
HIRAN C. SELVADURAI ◽  
KAREN O. McKAY ◽  
CAMERON J. BLIMKIE ◽  
PETER J. COOPER ◽  
CRAIG M. MELLIS ◽  
...  

2021 ◽  
Author(s):  
◽  
Mayara S. Bianchim

Cystic Fibrosis (CF) is a multisystemic condition that affects almost every organ in the body, but especially the lungs. Regular physical activity (PA) can significantly slow disease progression and has become a crucial part of CF care. Previous research evaluating PA in CF has been hindered by the use of cut-points developed for healthy populations and the investigation of collinear movement behaviours as independent entities, both of which are likely to have confounded their findings and any subsequent inferences regarding associated health outcomes. Therefore, the overall aim of this thesis was to investigate the measurement and analysis of PA in those with CF. An initial systematic review provided recommendations for research calibrating accelerometry in paediatric clinical populations, highlighting that the pathophysiology of the condition must be accounted for and that the protocol should include a broad range of activities varying in intensity (Chapter 4). Subsequently, Chapter 5 developed and cross-validated raw acceleration CF-specific cut-points in youth which were then further assessed in Chapter 6, demonstrating that the CF-specific thresholds were associated with higher levels of moderate-to-vigorous physical activity (MVPA) and sedentary time (SED) and lower levels of light PA compared to generic cut-points. Furthermore, lung function was associated with light PA when using condition-specific thresholds. Further investigation of the relationship between PA and health in Chapter 7 found that reallocating time from sedentary to any other behaviour was beneficial for lung function, with the greatest improvements observed when SED was reallocated to sleep or MVPA. Finally, Chapter 8 developed and validated machine learning algorithms that achieved excellent accuracy to classify PA types and intensities in youth with CF. In conclusion, these findings significantly advance the assessment of PA, enhancing our understanding of the relationship between PA and health in CF and informing future condition-specific PA guidelines, care strategies and interventions.


1993 ◽  
Vol 37 (3) ◽  
pp. 265-269 ◽  
Author(s):  
E B K WONG ◽  
J REGNIS ◽  
R C SHNIER ◽  
P T P BYE ◽  
M E B STEWART

Heart & Lung ◽  
2016 ◽  
Vol 45 (3) ◽  
pp. 283-290 ◽  
Author(s):  
Erik H. Van Iterson ◽  
Courtney M. Wheatley ◽  
Sarah E. Baker ◽  
Wayne J. Morgan ◽  
Eric M. Snyder

2013 ◽  
Vol 12 ◽  
pp. S67 ◽  
Author(s):  
L. Fila ◽  
A. Grandcourtova ◽  
M. Vichova ◽  
L. Valentova Bartakova

Author(s):  
AESHA JOBANPUTRA ◽  
Sugeet Jagpal ◽  
Paula Marulanda ◽  
MAYA RAMAGOPAL ◽  
TEODORO SANTIAGO ◽  
...  

Noninvasive ventilation (NIV) use was initially reported in cystic fibrosis (CF) in 1991 as a bridge to lung transplantation, and over the decades the use of NIV has increased in the CF population. Individuals with CF are prone to various physiologic changes as lung function worsens, and they may benefit from NIV for advanced lung disease. As life expectancy in CF has been increasing due to advances such as highly effective modulator therapy, people with CF are now subject to the same co-morbidities that may benefit from NIV as their age matched cohorts. NIV can improve gas exchange, quality of sleep, exercise tolerance and augment airway clearance in CF, and it is important that CF providers are comfortable with this therapeutic modality. In this review, we will summarize the physiologic basis for NIV use in CF, describe indications for initiation of NIV, and postulate a practical approach for CF clinicians to take fin monitoring patients on NIV. We will discuss aspects unique to people with CF and the use of NIV. We hope that this serves as a resource for CF providers, especially those of us who do not have dedicated training in sleep medicine, as we continue to care for our patient population.


Sign in / Sign up

Export Citation Format

Share Document